ATE296094T1 - Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen - Google Patents

Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen

Info

Publication number
ATE296094T1
ATE296094T1 AT02747613T AT02747613T ATE296094T1 AT E296094 T1 ATE296094 T1 AT E296094T1 AT 02747613 T AT02747613 T AT 02747613T AT 02747613 T AT02747613 T AT 02747613T AT E296094 T1 ATE296094 T1 AT E296094T1
Authority
AT
Austria
Prior art keywords
treatment
infections
nailbed
nitrogen monoxide
forming compositions
Prior art date
Application number
AT02747613T
Other languages
English (en)
Inventor
Nigel Benjamin
Original Assignee
Univ Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Aberdeen filed Critical Univ Aberdeen
Application granted granted Critical
Publication of ATE296094T1 publication Critical patent/ATE296094T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AT02747613T 2001-08-03 2002-08-02 Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen ATE296094T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0119011.5A GB0119011D0 (en) 2001-08-03 2001-08-03 Treatment of nail infections
PCT/GB2002/003575 WO2003013489A1 (en) 2001-08-03 2002-08-02 Treatment of nail infections with no

Publications (1)

Publication Number Publication Date
ATE296094T1 true ATE296094T1 (de) 2005-06-15

Family

ID=9919789

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02747613T ATE296094T1 (de) 2001-08-03 2002-08-02 Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen

Country Status (23)

Country Link
US (2) US20050037093A1 (de)
EP (1) EP1411908B1 (de)
JP (1) JP2005501069A (de)
KR (1) KR20040031780A (de)
CN (1) CN1321633C (de)
AT (1) ATE296094T1 (de)
AU (1) AU2002318001B2 (de)
BR (1) BR0211390A (de)
CA (1) CA2453243C (de)
DE (1) DE60204322T2 (de)
ES (1) ES2242042T3 (de)
GB (1) GB0119011D0 (de)
HR (1) HRP20040059B1 (de)
HU (1) HUP0401190A3 (de)
IL (2) IL159724A0 (de)
MX (1) MXPA04000670A (de)
NO (1) NO20040258L (de)
NZ (1) NZ530577A (de)
PL (1) PL213555B1 (de)
PT (1) PT1411908E (de)
RU (1) RU2298403C2 (de)
WO (1) WO2003013489A1 (de)
ZA (1) ZA200400491B (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
EP1653978B1 (de) * 2003-07-09 2020-06-03 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Vervendung von nitritsalzen zur behandlung von cardiovaskulären erkrankungen
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
JP5042209B2 (ja) * 2005-03-24 2012-10-03 ノーラブズ エービー 酸化窒素による美容治療、前記治療を実施する装置、及びその製造方法
US8557300B2 (en) * 2005-05-19 2013-10-15 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
EP1888510A4 (de) 2005-05-27 2013-01-16 Univ North Carolina Stickoxidfreisetzende partikel für stickoxidtherapeutika und biomedizinische anwendungen
JP5165217B2 (ja) * 2006-07-07 2013-03-21 生化学工業株式会社 ゲル状又はフィルム状組成物並びにその製造方法及び用途
GB0618711D0 (en) * 2006-09-22 2006-11-01 Univ Exeter Agricultural treatment
US20090130233A1 (en) * 2007-10-24 2009-05-21 Baker Christopher G Two part lotion
US9649334B2 (en) 2007-11-15 2017-05-16 The Uab Research Foundation Use of nitrite salts in chronic ischemia
AU2008345034A1 (en) * 2007-12-27 2009-07-09 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide - donating compounds and uses thereof
US8303995B1 (en) * 2008-06-13 2012-11-06 Board Of Regents, The University Of Texas System Nitrite formulations and their use as nitric oxide prodrugs
WO2010044875A2 (en) * 2008-10-16 2010-04-22 Novan, Inc. Nitric oxide releasing particles for oral care applications
US20120003293A1 (en) * 2008-10-30 2012-01-05 Chris Miller Nitric oxide-releasing dressings
BR112012003804B1 (pt) 2009-08-21 2019-02-19 Novan, Inc. Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento
BR112012003792B1 (pt) 2009-08-21 2020-05-19 Novan Inc composição tópica, e, uso da composição tópica
BR112012008508A2 (pt) * 2009-10-13 2017-06-13 Novan Inc revestimento de sol-gel, substrato, método para produzir um revestimento de sol-gel
CA2777066C (en) * 2009-10-14 2020-02-18 TheraVasc, LLC Pharmaceutical formulations of nitrite and uses thereof
WO2011155887A1 (en) * 2010-06-07 2011-12-15 Topical Pharma Ab Kit for the treatment of onychomycosis by nitric oxide
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
ES2695173T3 (es) 2011-02-28 2019-01-02 Novan Inc Partículas de sílice modificadas con S-nitrosotiol que liberan óxido nítrico y procedimientos de fabricación de las mismas
EP2691087A2 (de) 2011-03-31 2014-02-05 László Gábor Szabó Pharmazeutische zusammensetzung mit no, verfahren zu ihrer herstellung und verwendung
JP6277124B2 (ja) 2011-07-05 2018-02-07 ノヴァン，インコーポレイテッド 局所用組成物
US9737362B2 (en) * 2011-07-06 2017-08-22 Boston Scientific Scimed, Inc. Tissue cutting systems and methods
MX354702B (es) * 2011-08-17 2018-03-16 Univ Texas Metodo de produccion de niveles fisiologicos y terapeuticos de oxido nitrico por medio de un sistema de suministro oral.
EP2833721B1 (de) 2012-03-14 2021-02-17 Novan Inc. Stickoxid freisetzende pharmazeutische zusammensetzungen
CN105358160A (zh) 2013-02-20 2016-02-24 瑟阿瓦斯克公司 亚硝酸盐的药物制剂及其用途
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
US12233289B2 (en) 2013-08-01 2025-02-25 Olaplex, Inc. Methods for fixing hair and skin
US9095518B2 (en) 2013-08-01 2015-08-04 Liqwd, Inc. Methods for fixing hair and skin
BR112016002387B1 (pt) 2013-08-08 2019-05-21 Novan, Inc. Composições farmacêuticas tópicas, e método para seu armazenamento
CA2946828A1 (en) 2014-03-14 2015-09-17 Nitric Solutions, Inc. Treating diseases using nitric oxide releasing solutions
PT3142637T (pt) 2014-05-16 2020-10-15 Olaplex Inc Formulações e métodos de tratamento de queratina
CN106659675B (zh) 2014-07-11 2023-07-04 诺万公司 局部抗病毒组合物和其使用方法
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
WO2016010988A1 (en) 2014-07-14 2016-01-21 Novan, Inc. Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same
CN105813617B (zh) 2014-08-08 2021-05-28 诺万公司 局部用组合物和使用所述组合物的方法
US9597273B2 (en) 2015-04-24 2017-03-21 Liqwd, Inc. Methods for treating relaxed hair
US10849864B2 (en) 2015-07-28 2020-12-01 Novan, Inc. Combinations and methods for the treatment and/or prevention of fungal infections
EP3423100A4 (de) 2016-03-02 2019-10-16 Novan, Inc. Zusammensetzungen zur behandlung von entzündungen und verfahren zur behandlung davon
BR112018070578A2 (pt) 2016-04-13 2019-02-12 Novan, Inc. composições, sistemas, kits, e métodos para tratar uma infecção
US9872821B1 (en) 2016-07-12 2018-01-23 Liqwd, Inc. Methods and formulations for curling hair
US11534382B2 (en) 2017-06-19 2022-12-27 Novan, Inc. Topical compositions and methods of using the same
US11285171B2 (en) 2018-03-01 2022-03-29 Novan, Inc. Nitric oxide releasing suppositories and methods of use thereof
EP3764793A4 (de) 2018-03-13 2021-12-22 SaNOtize Research and Developmemt Corp. Stickoxid freisetzende zusammensetzungen
RU2704782C1 (ru) * 2018-10-09 2019-10-30 Елена Владимировна Герасимчук Способ криогенного лечения онихомикоза
US20220257642A1 (en) 2019-06-04 2022-08-18 Thirty Respiratory Limited Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
AU2020286677B2 (en) 2019-06-04 2025-12-04 Thirty Holdings Limited Methods and compositions for generating nitric oxide and uses thereof
WO2021214439A1 (en) 2020-04-23 2021-10-28 Thirty Respiratory Limited Methods and compositions for treating and combatting tuberculosis
WO2021214440A1 (en) 2020-04-23 2021-10-28 Thirty Respiratory Limited Nitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2
CN116615188A (zh) * 2020-07-16 2023-08-18 萨诺蒂泽研究开发公司 治疗对一氧化氮疗法有反应的状况的方法
RU2769437C1 (ru) * 2021-07-08 2022-03-31 Светлана Николаевна Абрамова Способ восстановления роста ногтя

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY128187A (en) * 1993-06-23 2007-01-31 Icn Switzerland Ag Preparation for skin and mucous membrane
CN1145491C (zh) 1994-02-21 2004-04-14 阿伯丁大学 用作抗微生物剂的酸化亚硝酸盐
GB9804469D0 (en) * 1998-03-02 1998-04-29 Univ Aberdeen Antiviral composition
US6709681B2 (en) * 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide

Also Published As

Publication number Publication date
NO20040258L (no) 2004-03-29
NZ530577A (en) 2007-01-26
MXPA04000670A (es) 2004-10-27
GB0119011D0 (en) 2001-09-26
PT1411908E (pt) 2005-08-31
JP2005501069A (ja) 2005-01-13
RU2004101765A (ru) 2005-03-10
HUP0401190A2 (hu) 2004-11-29
IL159724A (en) 2006-04-10
DE60204322T2 (de) 2006-01-26
BR0211390A (pt) 2004-08-17
PL213555B1 (pl) 2013-03-29
CN1321633C (zh) 2007-06-20
HUP0401190A3 (en) 2008-08-28
IL159724A0 (en) 2004-06-20
KR20040031780A (ko) 2004-04-13
US20100015253A1 (en) 2010-01-21
EP1411908B1 (de) 2005-05-25
WO2003013489A1 (en) 2003-02-20
ZA200400491B (en) 2005-04-22
US9381381B2 (en) 2016-07-05
AU2002318001B2 (en) 2007-02-15
HRP20040059B1 (hr) 2008-05-31
CN1564681A (zh) 2005-01-12
US20050037093A1 (en) 2005-02-17
RU2298403C2 (ru) 2007-05-10
EP1411908A1 (de) 2004-04-28
HRP20040059A2 (en) 2004-08-31
PL366579A1 (en) 2005-02-07
CA2453243C (en) 2012-01-03
CA2453243A1 (en) 2003-02-20
DE60204322D1 (de) 2005-06-30
ES2242042T3 (es) 2005-11-01

Similar Documents

Publication Publication Date Title
ATE296094T1 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
DE602004024572D1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
EA200500169A1 (ru) Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение
TW200510416A (en) P38 inhibitors and methods of use thereof
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
UA88645C2 (ru) Гетероарильные соединения как бета-миметики для лечения заболеваний дыхательных путей
BR0211761A (pt) depsipeptìdeos e processos para preparar os mesmos
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
NO20055741L (no) Nye kjemiske forbindelser
ATE323693T1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
MXPA04002282A (es) Nuevos compuestos y preparaciones como inhibidores de la catepsina.
CY1113871T1 (el) Διαδικασια παρασκευης γκαμπαπεντινης
MXPA05009014A (es) Antagonistas del receptor ccr-3.
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
ATE335739T1 (de) Cak inhibitoren und deren verwendungen
EA200600992A1 (ru) Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
CY1108980T1 (el) Χρηση πολυσουλφωμενων κυκλοδεξτρινων για τη θεραπεια της αρθριτιδας
ATE460168T1 (de) Nicht-radioaktives strontiummittel zur behandlung von krebs
EA200701852A1 (ru) Производные аминокислот
SE0100374D0 (sv) Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1411908

Country of ref document: EP

REN Ceased due to non-payment of the annual fee